SPONSOR
Biocity Biopharmaceutics Co., Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 1, Phase 2
Biocity Biopharmaceutics Co., Ltd. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Advanced Solid Malignancies, Locally Advanced or Metastatic Solid Tumors.
The trial portfolio spans Phase 1, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Biocity Biopharmaceutics Co., Ltd.
How many clinical trials has Biocity Biopharmaceutics Co., Ltd. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Biocity Biopharmaceutics Co., Ltd., of which 2 are actively recruiting participants. These trials cover conditions including Advanced Solid Malignancies, Locally Advanced or Metastatic Solid Tumors. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Biocity Biopharmaceutics Co., Ltd. research focus on?
Biocity Biopharmaceutics Co., Ltd. clinical trials span Advanced Solid Malignancies, Locally Advanced or Metastatic Solid Tumors. The research pipeline includes Phase 1, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Biocity Biopharmaceutics Co., Ltd. clinical trial?
To participate in a Biocity Biopharmaceutics Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Biocity Biopharmaceutics Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Biocity Biopharmaceutics Co., Ltd.
NCT07368478 Phase 1
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC2027 in Patients With Advanced Solid Malignancies
Advanced Solid Malignancies
NCT07469774 Phase 1, Phase 2
Recruiting
BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Locally Advanced or Metastatic Solid Tumors
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology